Munich, Germany

Sigrid Müller

This inventor holds 1 USPTO granted patent. Top assignee: Agrobiogen Gmbh. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sigrid Müller. Retrieved from https://idiyas.com/inventor/sigrid-manduumlller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sigrid Müller: Innovator in Cloning Technology

Introduction

Sigrid Müller is a notable inventor based in Munich, Germany. She has made significant contributions to the field of cloning technology, particularly in the efficient reproduction of animal embryos.

Latest Patents

Sigrid Müller holds a patent for "Efficient nuclear transfer using fetal fibroblasts and multiple cloning procedures." This invention relates to a process for breeding animals through cloning, focusing on the reproduction of animal embryos via an efficient nucleus transfer with fetal fibroblasts. She has 1 patent to her name.

Career Highlights

Sigrid Müller is associated with AgroBioGen GmbH, where she applies her expertise in cloning and animal reproduction technologies. Her work has paved the way for advancements in genetic research and animal breeding.

Collaborations

Sigrid has collaborated with notable colleagues such as Gottfried Brem and Gabriela Durcova-Hills, contributing to various projects in the field of biotechnology.

Conclusion

Sigrid Müller is a pioneering inventor whose work in cloning technology has the potential to revolutionize animal breeding practices. Her contributions continue to influence the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…